Atlas Trials

Clinical Study to Assess the Long-term Effect of Pep2Dia® on Glucose Homeostasis in Prediabetic Subjects

Clinical trial NCT05391854 · COMPLETED

Trial details

NCT number
NCT05391854
Sponsor
Ingredia S.A.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Prediabetic State
Start date
2022-06-21
Primary completion
2023-05-05
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.